Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human CHRNA2 ELISA Kit (AC3618)
Cat.#: ASET-2207
Specifications
Description Human CHRNA2 ELISA Kit allows for the in vitro quantitative determination of human CHRNA2 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15.625-1000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1940 Porcine beta Nerve Growth Factor ELISA Kit (AC3351) Quantitative inquiry ASET-2259 Human NRSN2 ELISA Kit (AC3670) Quantitative inquiry ASET-2510 Mouse beta 1 Adrenergic Receptor ELISA Kit (AC3921) Quantitative inquiry ASET-2169 Human Thrombospondin 1 ELISA Kit (AC3580) Quantitative inquiry ASET-1747 Porcine Angiogenin ELISA Kit (AC3158) Quantitative inquiry ASET-2464 Human CRY2 ELISA Kit (AC3875) Quantitative inquiry ASET-2495 Human GIRK1 ELISA Kit (AC3906) Quantitative inquiry ASET-2124 Human GDF11 ELISA Kit (AC3535) Quantitative inquiry ASET-1566 Rabbit Luteinizing Hormone ELISA Kit (AC2977) Quantitative inquiry ASET-2520 Rat MMP24 ELISA Kit (AC3931) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket